1. Additional file 1 of A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma
- Author
-
Liu, Qixian, Li, Ruiyu, Wu, Huanwen, and Liang, Zhiyong
- Abstract
Additional file 1. Supplementary File S1. Cuproptosis-related genes selected by genome-wideCRISPR-Cas9 loss-of-function screens after treatment with elesclomol-copper inOVISE cells. Supplementary Table 1. Differences in clinicopathological characteristics betweenICGC training set and ICGC validation set. Supplementary Figure 1. The hazard ratio of three genes was calculated bymultivariate Cox regression analysis in the prognostic model. Supplementary Figure 2. Evaluation of prognostic model in the GEO testing set. (A)The risk score, survival time, survival status, and 3-gene expression trend in thetesting set (GSE85916, 80 samples). (B) ROC curves for the sensitivity andspecificity of one-, two-, and three-year OS according to the risk score in theGEO-testing set. (C) Kaplan–Meier curve for OS between the high- and low-riskgroups in the GEO-testing set. Supplementary Figure 3. Comparison of the molecular characteristics and immunelandscapes between the risk groups. (A) Correlation between the risk score and TMB.The Spearman correlation coefficients (R) and corresponding p values are shown. (B)The relationship between the risk score and MSI in TCGA-PAAD cohort. (C) Theexpression levels of representative immune checkpoint genes in the high- andlow-risk PAAD patients from the TCGA cohort. * p < 0.05; ** p < 0.01; *** P
- Published
- 2023
- Full Text
- View/download PDF